Biography:
Erwin L Roggen holds a PhD in Biochemistry (B) with extensive expertise in protein chemistry, molecular biology, microbiology, immunology, and cell biology. He has 35 years of experience working within industry (Novo Nordisk, Novozymes).
He founded 3Rs Management and Consulting ApS (DK), promoting application of mechanism-based human relevant novel approach methods (NAMS) for risk assessment, co-founder of SenzaGen AB (S), specialized in cell-based solutions to identify skin and respiratory sensitizers, assuring sustainability of the Sens-it-iv GARD platform (on stock market in Sweden), co-founder of ToxGenSolutions BV.
Title : Application of AI and computational approaches supporting new generation healthcare aiming at prevention with focus on gender differences